Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Shanghai BravoBio Licenses China Rights to Rotavirus Vaccine

06:52 EDT 28 Jun 2013 | ChinaBio Today

Shanghai BravoBio Co. has in-licensed China rights to RotaShield®, an oral rotavirus vaccine that was developed by the International Medica Foundation of the US. The vaccine is the first that can be given to newborns, and it requires only two dos...

Original Article: Shanghai BravoBio Licenses China Rights to Rotavirus Vaccine

NEXT ARTICLE

More From BioPortfolio on "Shanghai BravoBio Licenses China Rights to Rotavirus Vaccine"

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Story